Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-16-059043
Filing Date
2016-03-25
Accepted
2016-03-25 16:15:41
Documents
1
Period of Report
2015-12-28

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 4480
  Complete submission text file 0001140361-16-059043.txt   5796
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Issuer) CIK: 0001302573 (see all company filings)

EIN.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 61 HARTFORD STREET SAN FRANCISCO CA 94114
Business Address
HASTINGS PAUL J (Reporting) CIK: 0001309702 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35993 | Film No.: 161529864